Vertex Pharmaceuticals, Inc. (VRTX)
544.52
+2.83
(+0.52%)
USD |
NASDAQ |
Aug 31, 16:00
545.00
+0.48
(+0.09%)
After-Hours: 20:00
Vertex Pharmaceuticals Total Long Term Debt (Quarterly) : 1.978B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.978B |
| March 31, 2026 | 1.986B |
| December 31, 2025 | 1.959B |
| September 30, 2025 | 1.835B |
| June 30, 2025 | 1.527B |
| March 31, 2025 | 1.649B |
| December 31, 2024 | 1.662B |
| September 30, 2024 | 1.703B |
| June 30, 2024 | 933.40M |
| March 31, 2024 | 721.30M |
| December 31, 2023 | 775.30M |
| September 30, 2023 | 744.70M |
| June 30, 2023 | 767.60M |
| March 31, 2023 | 789.20M |
| December 31, 2022 | 851.10M |
| September 30, 2022 | 824.60M |
| June 30, 2022 | 847.30M |
| March 31, 2022 | 872.50M |
| December 31, 2021 | 934.10M |
| September 30, 2021 | 876.80M |
| June 30, 2021 | 893.85M |
| March 31, 2021 | 898.80M |
| December 31, 2020 | 931.94M |
| September 30, 2020 | 546.51M |
| June 30, 2020 | 522.07M |
| Date | Value |
|---|---|
| March 31, 2020 | 532.95M |
| December 31, 2019 | 661.66M |
| September 30, 2019 | 641.60M |
| June 30, 2019 | 649.01M |
| March 31, 2019 | 659.59M |
| December 31, 2018 | 591.37M |
| September 30, 2018 | 588.04M |
| June 30, 2018 | 592.74M |
| March 31, 2018 | 595.12M |
| December 31, 2017 | 606.43M |
| September 30, 2017 | 587.19M |
| June 30, 2017 | 568.54M |
| March 31, 2017 | 548.40M |
| December 31, 2016 | 540.76M |
| September 30, 2016 | 820.32M |
| June 30, 2016 | 820.63M |
| March 31, 2016 | 824.49M |
| December 31, 2015 | 826.53M |
| September 30, 2015 | 820.98M |
| June 30, 2015 | 824.47M |
| March 31, 2015 | 833.91M |
| December 31, 2014 | 824.95M |
| September 30, 2014 | 828.24M |
| June 30, 2014 | 538.03M |
| March 31, 2014 | 541.18M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 26.25B |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Sionna Therapeutics, Inc. | 6.692M |
| Regeneron Pharmaceuticals, Inc. | 2.707B |
| Biogen, Inc. | 8.355B |